These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17054047

  • 1. Liver enzyme-mediated oxidation of Echinacea purpurea alkylamides: production of novel metabolites and changes in immunomodulatory activity.
    Cech NB, Tutor K, Doty BA, Spelman K, Sasagawa M, Raner GM, Wenner CA.
    Planta Med; 2006 Dec; 72(15):1372-7. PubMed ID: 17054047
    [Abstract] [Full Text] [Related]

  • 2. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes.
    Matthias A, Gillam EM, Penman KG, Matovic NJ, Bone KM, De Voss JJ, Lehmann RP.
    Chem Biol Interact; 2005 Jun 30; 155(1-2):62-70. PubMed ID: 15885678
    [Abstract] [Full Text] [Related]

  • 3. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells.
    Sasagawa M, Cech NB, Gray DE, Elmer GW, Wenner CA.
    Int Immunopharmacol; 2006 Jul 30; 6(7):1214-21. PubMed ID: 16714226
    [Abstract] [Full Text] [Related]

  • 4. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts.
    Chicca A, Raduner S, Pellati F, Strompen T, Altmann KH, Schoop R, Gertsch J.
    Int Immunopharmacol; 2009 Jul 30; 9(7-8):850-8. PubMed ID: 19303464
    [Abstract] [Full Text] [Related]

  • 5. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
    Modarai M, Gertsch J, Suter A, Heinrich M, Kortenkamp A.
    J Pharm Pharmacol; 2007 Apr 30; 59(4):567-73. PubMed ID: 17430641
    [Abstract] [Full Text] [Related]

  • 6. Metabolism of the major Echinacea alkylamide N-isobutyldodeca-2E,4E,8Z,10Z-tetraenamide by human recombinant cytochrome P450 enzymes and human liver microsomes.
    Toselli F, Matthias A, Bone KM, Gillam EM, Lehmann RP.
    Phytother Res; 2010 Aug 30; 24(8):1195-201. PubMed ID: 20135639
    [Abstract] [Full Text] [Related]

  • 7. Effects of herbal products and their constituents on human cytochrome P450(2E1) activity.
    Raner GM, Cornelious S, Moulick K, Wang Y, Mortenson A, Cech NB.
    Food Chem Toxicol; 2007 Dec 30; 45(12):2359-65. PubMed ID: 17658211
    [Abstract] [Full Text] [Related]

  • 8. Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.
    Gulledge TV, Collette NM, Mackey E, Johnstone SE, Moazami Y, Todd DA, Moeser AJ, Pierce JG, Cech NB, Laster SM.
    J Ethnopharmacol; 2018 Feb 15; 212():166-174. PubMed ID: 29042288
    [Abstract] [Full Text] [Related]

  • 9. Echinacea alkylamides modulate induced immune responses in T-cells.
    Matthias A, Banbury L, Bone KM, Leach DN, Lehmann RP.
    Fitoterapia; 2008 Jan 15; 79(1):53-8. PubMed ID: 17855021
    [Abstract] [Full Text] [Related]

  • 10. Analysis of alkylamides in Echinacea plant materials and dietary supplements by ultrafast liquid chromatography with diode array and mass spectrometric detection.
    Mudge E, Lopes-Lutz D, Brown P, Schieber A.
    J Agric Food Chem; 2011 Aug 10; 59(15):8086-94. PubMed ID: 21702479
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect on prolactin secretion of Echinacea purpurea, hypericum perforatum and Eleutherococcus senticosus.
    Di Carlo G, Pacilio M, Capasso R, Di Carlo R.
    Phytomedicine; 2005 Sep 10; 12(9):644-7. PubMed ID: 16194051
    [Abstract] [Full Text] [Related]

  • 13. Alkylamides from echinacea modulate induced immune responses in macrophages.
    Matthias A, Banbury L, Stevenson LM, Bone KM, Leach DN, Lehmann RP.
    Immunol Invest; 2007 Sep 10; 36(2):117-30. PubMed ID: 17365014
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Echinacea metabolism and drug interactions: the case for standardization of a complementary medicine.
    Toselli F, Matthias A, Gillam EM.
    Life Sci; 2009 Jul 17; 85(3-4):97-106. PubMed ID: 19427870
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Bioavailability of Echinacea constituents: Caco-2 monolayers and pharmacokinetics of the alkylamides and caffeic acid conjugates.
    Matthias A, Penman KG, Matovic NJ, Bone KM, De Voss JJ, Lehmann RP.
    Molecules; 2005 Oct 30; 10(10):1242-51. PubMed ID: 18007516
    [Abstract] [Full Text] [Related]

  • 18. Echinacea purpurea-derived alkylamides exhibit potent anti-inflammatory effects and alleviate clinical symptoms of atopic eczema.
    Oláh A, Szabó-Papp J, Soeberdt M, Knie U, Dähnhardt-Pfeiffer S, Abels C, Bíró T.
    J Dermatol Sci; 2017 Oct 30; 88(1):67-77. PubMed ID: 28610718
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.